Victory Capital Management
SLS icon

Victory Capital Management’s SELLAS Life Sciences SLS Stock Holding History

Victory Capital Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$316K Buy
21,400
+5,352
+33% +$36.9K ﹤0.01% 2158
2026
Q1 		$67.9K Sell
16,048
-303
-2% -$1.36K ﹤0.01% 2296
2025
Q4 		$61.6K Buy
16,351
+4,481
+38% +$8.71K ﹤0.01% 2313
2025
Q3 		$19.1K Buy
11,870
+223
+2% +$397 ﹤0.01% 2399
2025
Q2 		$25.5K Buy
+11,647
New +$17.9K ﹤0.01% 2426
2020
Q2 		– Sell
-1,149
Closed -$2K – 3178
2020
Q1 		$2K Buy
+1,149
New +$2.96K ﹤0.01% 3534
2019
Q4 		– Sell
-793
Closed -$5K – 3190
2019
Q3 		$5K Buy
+793
New +$5.84K ﹤0.01% 3461

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Victory Capital Management's SLS Position: Q2 2026 in Review

Victory Capital Management increased its SELLAS Life Sciences (SLS) stake by 33% in Q2 2026, buying an estimated $36.9K and bringing the position to 21,400 shares worth $316K. The position accounts for ﹤0.01% of the portfolio, ranked #2158.

Victory Capital Management first reported a position in SLS in Q3 2019 and has held it in 7 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Victory Capital Management held 21,400 shares of SELLAS Life Sciences worth $316K as of Q2 2026.
  • Victory Capital Management bought 5,352 SELLAS Life Sciences shares in Q2 2026, an estimated $36.9K.
  • SELLAS Life Sciences made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2158 holding.
  • Victory Capital Management first reported a position in SELLAS Life Sciences in Q3 2019 and has held it in 7 quarters since.
  • 192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.